8-KThe WireStrategic
Material Agreement · Shareholder Vote
Filed Jun 12, 2025 · 1y ago · Accession 0001641172-25-014905
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kairos Pharma, LTD.
- Ticker
- KAPA
- CIK
- 1962011
- Form type
- 8-K
- Filing date
- Jun 12, 2025
- Report date
- Jun 10, 2025
- Document
- form8-k.htm
- Size
- 288 KB